Tyrosine kinase inhibitor BIBF 1120
Term · Oncology and biomedicine · MLC-T-ONC-009006
A substance being studied in the treatment of some types of cancer. Tyrosine kinase inhibitor BIBF 1120 blocks enzymes needed for cells to grow, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called BIBF 1120.
| Identifier | MLC-T-ONC-009006 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | BIBF 1120 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009006",
"term": "Tyrosine kinase inhibitor BIBF 1120",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of some types of cancer. Tyrosine kinase inhibitor BIBF 1120 blocks enzymes needed for cells to grow, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called BIBF 1120.",
"synonyms": [
"BIBF 1120"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/tyrosine-kinase-inhibitor-bibf-1120/"
}
Record 16,870 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.